Ambee Pharmaceuticals (DHA:AMBEEPHA) EPS (Basic): BDT (TTM As of . 20)


DHA:AMBEEPHA Ambee Pharmaceuticals Plc DHA:AMBEEPHA
18 GF Score
Price BDT754.00
View Full Analysis

What is Ambee Pharmaceuticals EPS (Basic)?

Ambee Pharmaceuticals DHA:AMBEEPHA +0.43% 18 EPS (Basic) is BDT as of . 20. GuruFocus rates DHA:AMBEEPHA with a GF Score™ of 18/100.

Ambee Pharmaceuticals's basic earnings per share (Basic EPS) for the six months ended in . 20 was BDT0.00. Ambee Pharmaceuticals does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in . 20.

Ambee Pharmaceuticals's EPS (Diluted) for the six months ended in . 20 was BDT0.00. Ambee Pharmaceuticals does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in . 20.

Ambee Pharmaceuticals's EPS without NRI for the six months ended in . 20 was BDT0.00. Ambee Pharmaceuticals does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Ambee Pharmaceuticals  (DHA:AMBEEPHA) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Ambee Pharmaceuticals EPS (Basic) Related Terms

Ambee Pharmaceuticals EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Ambee Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambee Pharmaceuticals EPS (Basic) Chart

Ambee Pharmaceuticals Annual Data
Trend
EPS (Basic)

Ambee Pharmaceuticals Semi-Annual Data
EPS (Basic)
DHA:AMBEEPHA
18GF Score
Ambee Pharmaceuticals Plc DHA:AMBEEPHA
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambee Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Ambee Pharmaceuticals's Basic EPS for the fiscal year that ended in . 20 is calculated as

Basic EPS (A: . 20 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-)/0
=

Ambee Pharmaceuticals's Basic EPS for the quarter that ended in . 20 is calculated as

Basic EPS (Q: . 20 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-)/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of BDT mean?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a EPS (Basic) of BDT as of . 20. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Ambee Pharmaceuticals and its competitors.
Is Ambee Pharmaceuticals' EPS (Basic) too high?
Ambee Pharmaceuticals' current EPS (Basic) is BDT. Overall, Ambee Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Ambee Pharmaceuticals' EPS (Basic) compare to IMNPQ?
Ambee Pharmaceuticals' EPS (Basic) of BDT can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Ambee Pharmaceuticals and its competitors. Ambee Pharmaceuticals's current EPS (Basic) is BDT. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambee Pharmaceuticals stock overvalued right now?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a current EPS (Basic) of BDT. The current EPS (Basic) is BDT. Ambee Pharmaceuticals' overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Ambee Pharmaceuticals (DHA:AMBEEPHA), the current EPS (Basic) is BDT as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ambee Pharmaceuticals Business Description

Address 184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208
Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.
18GF Score

Get the complete analysis for DHA:AMBEEPHA

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT754.00
Price